Endophthalmitis from Mycobacterium bovis-bacille Calmette-Guérin after intravesicular bacille Calmette-Guérin injections for bladder carcinoma

Am J Ophthalmol. 1999 Nov;128(5):648-50. doi: 10.1016/s0002-9394(99)00206-8.

Abstract

Purpose: To present clinical and histologic findings of intraocular infection with Mycobacterium bovis-bacille Calmette-Guérin after intravesicular bacille Calmette-Guérin injections for treatment of bladder carcinoma.

Methods: A 77-year-old man was initially seen with visual acuity of 20/200, focal retinitis, vasculitis, and progressive vitreous opacity in the right eye and visual acuity of light perception, intraocular inflammation, and a dense cataract in the left eye 14 months after intravesicular injection of live bacille Calmette-Guérin organisms.

Results: Vitreous cultures in the right eye demonstrated growth of bacille Calmette-Guérin organisms. Bilateral loss of light perception occurred despite systemic antimy-cobacterial therapy. Histopathologic examination demonstrated nongranulomatous inflammation and acid-fast bacilli in both eyes.

Conclusion: Delayed endogenous endophthalmitis may develop after intravesicular bacille Calmette-Guérin injection that may not respond to systemic agents. Intravitreal therapy may be indicated.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Carcinoma / therapy*
  • Endophthalmitis / microbiology*
  • Endophthalmitis / pathology
  • Endophthalmitis / surgery
  • Eye / pathology
  • Eye Enucleation
  • Humans
  • Injections
  • Male
  • Mycobacterium Infections / etiology*
  • Mycobacterium bovis* / isolation & purification
  • Urinary Bladder Neoplasms / therapy*
  • Vitreous Body / microbiology